Lakeside signs $1.5 million sales agreement with sinopharm group subsidiary

Agreement to deliver critical medicines  itasca, ill. , dec. 17, 2024 /prnewswire/ -- lakeside holding limited ("lakeside" or the "company") (nasdaq: lsh), a u.s.-based cross-border supply chain solution provider with a unique focus on the asia-pacific market is pleased to announce that hupan pharmaceutical has signed a sales agreement (the "agreement") with sinopharm holding hubei new special medicine co., ltd.
LSH Ratings Summary
LSH Quant Ranking